Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 28, 2024; 30(8): 811-816
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.811
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.811
Ref. | n | Type of study | FNA or FNB | Incidence |
Ribeiro et al[17], 2018 | 712 | Prospective cohort | FNA and FNB | 16/712 (2.2%) |
Thomsen et al[18], 2022 | 852 | Retrospective cohort | FNB | 20/852 (2.3%) |
Kandel et al[16], 2021 | 50 | Prospective RCT | FNA and FNB | 2/50 (4.0%) |
van Riet et al[19], 2019 | 608 | Prospective RCT | FNA and FNB | 2/608 (0.3%) |
Gonzalez et al[14], 2022 | 105 | Retrospective cohort | FNA and FNB | 0/105 (0.0%) |
Ishigaki et al[15], 2020 | 154 | Retrospective cohort | FNA and FNB | 2/154 (1.3%) |
Chen et al[13], 2022 | 235 | Prospective RCT | FNA and FNB | 2/235 (0.9%) |
- Citation: de Jong M, van Delft F, Roozen C, van Geenen EJ, Bisseling T, Siersema P, Bruno M. Nonsteroidal anti-inflammatory drugs before endoscopic ultrasound guided tissue acquisition to reduce the incidence of post procedural pancreatitis. World J Gastroenterol 2024; 30(8): 811-816
- URL: https://www.wjgnet.com/1007-9327/full/v30/i8/811.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i8.811